|
Breast Cancer Res publishes selected research, proceedings and collections of thematic reviews as supplements. All articles published in supplements are subject to peer review and are free to access online. The journal also publishes supplements containing meeting abstracts.
Contents of Volume 2 Suppl 1
Second International Symposium on the Molecular Biology of Breast Cancer
Meeting abstracts
from Second International Symposium on the Molecular Biology of Breast Cancer
Lillehammer, Norway. 12  16 March 2000
|
Meeting abstract
Denaturing high-performance liquid chromatography (DHPLC) as a fast tool to screen a control population for the occurrence of unclassified variants (UV) in the BRCA1 gene
N Arnold, E Gross, H Peper, K Bandick, W Jonat, M Kiechle
Breast Cancer Res 2000, 2(Suppl 1):P1.01 (12 March 2000)
[Full text] [PDF]
Meeting abstract
Clinical and pathological characteristics in patients with BRCA1/2-mutation associated with breast cancer (BC) with a long clinical follow-up
O Díez, C Pericay, M Domènech, J Brunet, J Cortés, J Balmaña, A Gómez, JJ López, MC Alonso, M Baiget
Breast Cancer Res 2000, 2(Suppl 1):P1.02 (12 March 2000)
[Full text] [PDF]
Meeting abstract
A novel BRCA2 gene mutation, 4081 insA, in a Finnish breast/ovarian cancer family associated with favourable clinical course
J Hartikainen, V Kataja, A Mannermaa
Breast Cancer Res 2000, 2(Suppl 1):P1.03 (12 March 2000)
[Full text] [PDF]
Meeting abstract
Breast cancer in young women: prevalence of LOH at p53, BRCA1 and BRCA2
SM Johnson, JA Shaw, RA Walker
Breast Cancer Res 2000, 2(Suppl 1):P1.04 (12 March 2000)
[Full text] [PDF]
Meeting abstract
BRCA1 mutation analysis in breast and ovarian cancer families from Greece
I Konstantopoulou, C Croupis, A Ladopoulou, A Pantazidis, E Lianidou, K Venetsanou, E Efstathiou, M Petersen, J Janinis, G Fountzilas, E Chiotellis, D Yannoukakos
Breast Cancer Res 2000, 2(Suppl 1):P1.05 (12 March 2000)
[Full text] [PDF]
Meeting abstract
BRCA1, BRCA2 and pedigree genetic analysis to determine genetic risk in the UK Royal Marsden Hospital tamoxifen prevention trial
Z Kote-Jarai, TP Powles, S Ashley, DF Easton, L Assersohn, N Sodha, M Dowsett, B Gusterson, A Tidy, G Mitchell, RA Eeles
Breast Cancer Res 2000, 2(Suppl 1):P1.06 (12 March 2000)
[Full text] [PDF]
Meeting abstract
Mutational analysis of BRCA1 and BRCA2 genes in Spanish women with early-onset breast cancer
JI Martínez-Ferrandis, A Vega, P Marín-Garcia, F Barros, FJ Chaves, A Carracedo, ME Armengod, I Chirivella, A Lluch, J García-Conde, A Cervantes
Breast Cancer Res 2000, 2(Suppl 1):P1.07 (12 March 2000)
[Full text] [PDF]
Meeting abstract
One test to identify 50% of all Norwegian BRCA1 mutations
P Møller, E Hovig, K Lycke, RAP Stacy, OJ Dahlberg, A Hagen, B Hagen, K Løvslett, H Qvist, K Heimdal
Breast Cancer Res 2000, 2(Suppl 1):P1.08 (12 March 2000)
[Full text] [PDF]
Meeting abstract
Germline TP53 mutations in Finnish breast cancer patients
K Rapakko, M Allinen, K Syrjäkoski, P Vahteristo, P Huusko, K Vähäkangas, H Eerola, T Kainu, O-P Kallioniemi, H Nevanlinna, R Winqvist
Breast Cancer Res 2000, 2(Suppl 1):P1.09 (12 March 2000)
[Full text] [PDF]
Meeting abstract
X chromosome inactivation pattern in female patients with breast cancer
M Kristiansen, A Langer, GP Knudsen, BL Weber, A-L Børresen-Dale, KH Ørstavik
Breast Cancer Res 2000, 2(Suppl 1):P1.10 (12 March 2000)
[Full text] [PDF]
Meeting abstract
HRAS1 minisatellite alleles and breast cancer in Spanish women under age forty years
A Vega, JI Martínez, F Barros, P Marín-García, FJ Chavez, C Ruiz-Ponte, I Chirivella, A Lluch, A Cervantes, I García-Conde, ME Armengod, A Carracedo
Breast Cancer Res 2000, 2(Suppl 1):P1.11 (12 March 2000)
[Full text] [PDF]
Meeting abstract
Germline BRCA2 and somatic P53 alterations in male breast cancer
B Csokay, N Udvarhelyi, E Olah
Breast Cancer Res 2000, 2(Suppl 1):P1.12 (12 March 2000)
[Full text] [PDF]
Meeting abstract
Constitutional alterations of 9p23-24 in independent BRCA2 breast cancer families
M Schwab, L Savelyeva, A Claas, H An, S Brouwers
Breast Cancer Res 2000, 2(Suppl 1):P1.13 (12 March 2000)
[Full text] [PDF]
Meeting abstract
kConFab: a unique Australasian research initiative for familial breast cancer
J Sambrook
Breast Cancer Res 2000, 2(Suppl 1):P1.14 (12 March 2000)
[Full text] [PDF]
Meeting abstract
Germline mutations of BRCA1-associated RING domain (BARD1) gene in breast and/or ovarian families negative for BRCA1 and 2 alterations
C Ghimenti, E Sensi, D Iandolo, G Cipollini, S Ricci, PF Conte, G Bevilacqua, MA Caligo
Breast Cancer Res 2000, 2(Suppl 1):P1.15 (12 March 2000)
[Full text] [PDF]
Meeting abstract
Mammary-specific targeting of the murine BRCA2 breast cancer susceptibility gene in mice
NK Collins, KA McAllister, LM Bennett, K-U Wagner, T Ward, J Malphurs, G Goulding, EM Eddy, BJ Davis, RW Wiseman
Breast Cancer Res 2000, 2(Suppl 1):P1.16 (12 March 2000)
[Full text] [PDF]
Meeting abstract
Relative expression of progesterone receptors A and B in premalignant and invasive breast lesions
P Mote, C Clarke
Breast Cancer Res 2000, 2(Suppl 1):P2.01 (12 March 2000)
[Full text] [PDF]
Meeting abstract
Growth inhibition and growth stimulation by estradiol of estrogen receptor transfected human breast epithelial cell lines involve different pathways
BK Lundholt, P Briand, AE Lykkesfeldt
Breast Cancer Res 2000, 2(Suppl 1):P2.02 (12 March 2000)
[Full text] [PDF]
Meeting abstract
Hairy and enhancer of split homolog-1 (HES-1) mediates the proliferative effect of Beta-estradiol on breast cancer cell lines
A Ström, N Arai, J Leers, J-Å Gustafsson
Breast Cancer Res 2000, 2(Suppl 1):P2.03 (12 March 2000)
[Full text] [PDF]
Meeting abstract
Genetic variants of CYP19 (aromatase) and breast cancer risk
V Nedelcheva Kristensen, N Harada, N Yoshimura, E Haraldsen, PE Lønning, B Erikstein, R Kåresen, T Kristensen, A-L Børresen-Dale
Breast Cancer Res 2000, 2(Suppl 1):P2.04 (12 March 2000)
[Full text] [PDF]
|
